...
首页> 外文期刊>Nucleic Acids Research >Interaction between the N-terminal domain of human DNA topoisomerase I and the arginine-serine domain of its substrate determines phosphorylation of SF2/ASF splicing factor.
【24h】

Interaction between the N-terminal domain of human DNA topoisomerase I and the arginine-serine domain of its substrate determines phosphorylation of SF2/ASF splicing factor.

机译:人DNA拓扑异构酶I的N末端结构域及其底物的精氨酸-丝氨酸结构域之间的相互作用决定了SF2 / ASF剪接因子的磷酸化。

获取原文
获取原文并翻译 | 示例
           

摘要

Human DNA topoisomerase I, known for its DNA-relaxing activity, is possibly one of the kinases phosphorylating members of the SR protein family of splicing factors, in vivo. Little is known about the mechanism of action of this novel kinase. Using the prototypical SR protein SF2/ASF (SRp30a) as model substrate, we demonstrate that serine residues phosphorylated by topo I/kinase exclusively located within the most extended arginine-serine repeats of the SF2/ASF RS domain. Unlike other kinases such as cdc2 and SRPK1, which also phosphorylated serines at the RS domain, topo I/kinase required several SR dipeptide repeats. These repeats possibly contribute to a versatile structure in the RS domain thereby facilitating phosphorylation. Furthermore, far-western, fluorescence spectroscopy and kinase assays using the SF2/ASF mutants, demonstrated that kinase activity and binding were tightly coupled. Since the deletion of N-terminal 174 amino acids of Topo I destroys SF2/ASF binding and kinase activity but not ATP binding, we conclude that at least two distinct domains of Topo I are necessary for kinase activity: one in the C-terminal region contributing to the ATP binding site and the other one in the N-terminal region that allows binding of SF2/ASF.
机译:以其DNA松弛活性而闻名的人DNA拓扑异构酶I可能是体内SR蛋白家族剪接因子家族的激酶之一。关于这种新型激酶的作用机理知之甚少。使用原型SR蛋白SF2 / ASF(SRp30a)作为模型底物,我们证明了由topo I /激酶磷酸化的丝氨酸残基仅位于SF2 / ASF RS域的最延伸的精氨酸-丝氨酸重复序列内。与其他激酶(例如cdc2和SRPK1,后者也在RS结构域磷酸化丝氨酸)不同,topo I /激酶需要几个SR二肽重复序列。这些重复可能有助于RS结构域中的通用结构,从而促进磷酸化。此外,使用SF2 / ASF突变体的更远距离的荧光光谱和激酶测定表明,激酶活性和结合紧密相关。由于Topo I的N端174个氨基酸的缺失破坏了SF2 / ASF结合和激酶活性,但不破坏ATP结合,因此我们得出结论,Topo I的至少两个不同的域对于激酶活性是必需的:一个在C端区域有助于ATP结合位点,而另一个在N末端区域有助于SF2 / ASF结合。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号